ZCCHC10: A Drug Target / Disease Biomarker (G54819)

Target Name: ZCCHC10

NCBI ID: G54819

ZCCHC10

ZCCHC10: A Drug Target / Disease Biomarker

ZCCHC10 is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the zinc finger gene family, which is a family of transcription factors that play a crucial role in regulating gene expression. ZCCHC10 has been identified as a potential drug target and has been shown to be involved in a number of biological processes, including cell signaling, inflammation, and stress resistance.

The zinc finger gene family is characterized by the presence of a zinc finger domain in the protein sequence. This domain is responsible for the formation of a covalent complex with a specific DNA target, which is then involved in the regulation of gene expression. Zinc finger domains are found in a wide variety of proteins, including transcription factors, and are involved in the regulation of gene expression in a variety of organisms.

ZCCHC10 is a member of the zinc finger gene family and is expressed in various tissues of the body.

One of the key functions of zinc finger genes is to regulate gene expression. These genes are able to bind to specific DNA sequences and then regulate the activity of the transcription factors that bind to those sequences. This allows them to control the expression of genes that are involved in a wide range of biological processes, including development, growth, and repair.

ZCCHC10 has been shown to be involved in a number of biological processes, including cell signaling, inflammation, and stress resistance. For example, studies have shown that ZCCHC10 is involved in the regulation of cell signaling pathways, including the signaling pathways that are involved in cell growth, differentiation, and survival. It has also been shown to be involved in the regulation of inflammation and stress resistance, processes that are important for maintaining the health and function of the body.

In addition to its role in cell signaling and inflammation, ZCCHC10 is also thought to be involved in the regulation of stem cell biology. Studies have shown that zinc finger genes are involved in the regulation of stem cell self-renewal and differentiation, processes that are important for the development and maintenance of tissues and organs. This may be important for understanding the mechanisms that allow stem cells to develop into fully functional tissues and organs, and for the development of effective treatments for a variety of diseases.

As a potential drug target, ZCCHC10 is an attractive target for researchers to study because of its involvement in a wide range of biological processes. This makes it a promising candidate for the development of new treatments for a variety of diseases. For example, ZCCHC10 has been shown to be involved in the regulation of cell signaling pathways, which are important for many diseases, including cancer, cardiovascular disease, and neurological disorders. It may also be involved in the regulation of stem cell biology, which is important for the development and maintenance of tissues and organs.

In conclusion, ZCCHC10 is a protein that is expressed in various tissues of the body and is thought to be involved in a wide range of biological processes, including cell signaling, inflammation, and stress resistance. As a potential drug target, ZCCHC10 is an attractive candidate for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of ZCCHC10 in these biological processes and to determine its potential as a drug target.

Protein Name: Zinc Finger CCHC-type Containing 10

The "ZCCHC10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZCCHC10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets